Roivant Sciences Ltd. financial data

Symbol
ROIV on Nasdaq
Location
London
Fiscal year end
March 31
Latest financial report
10-Q - Q3 2025 - Nov 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.62K % +83.2%
Quick Ratio 8 %
Debt-to-equity 5.27 % -56.3%
Return On Equity -7.35 % -109%
Return On Assets -7.01 % -110%
Operating Margin -5.66K % -125%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 695M shares -4.46%
Common Stock, Shares, Outstanding 690M shares -5.95%
Entity Public Float 8.1B USD +1.25%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 681M shares -7.41%
Weighted Average Number of Shares Outstanding, Diluted 681M shares -7.41%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 20.3M USD +2.13%
Research and Development Expense 604M USD +30.4%
General and Administrative Expense 566M USD -29.5%
Operating Income (Loss) -1.15B USD -125%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -866M USD -118%
Income Tax Expense (Benefit) 35.4M USD -13.5%
Net Income (Loss) Attributable to Parent -374M USD -108%
Earnings Per Share, Basic 0 USD/shares -109%
Earnings Per Share, Diluted 0 USD/shares -109%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.24B USD -36.8%
Marketable Securities, Current 3.15B USD -8.15%
Cash, Cash Equivalents, and Short-term Investments 4.39B USD -18.6%
Inventory, Net 34M USD +705%
Other Assets, Current 126M USD +33.5%
Assets, Current 4.51B USD -22.2%
Property, Plant and Equipment, Net 25.7M USD +87.7%
Operating Lease, Right-of-Use Asset 85.1M USD +98.1%
Intangible Assets, Net (Excluding Goodwill) 136M USD -6.23%
Other Assets, Noncurrent 27.8M USD -24.6%
Assets 5.06B USD -18.4%
Accounts Payable, Current 15.1M USD -40%
Employee-related Liabilities, Current 26.4M USD -32.1%
Accrued Liabilities, Current 108M USD -2.83%
Liabilities, Current 134M USD -75.9%
Operating Lease, Liability, Noncurrent 89.8M USD +108%
Other Liabilities, Noncurrent 170K USD -42.4%
Liabilities 257M USD -58.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 19.6M USD
Retained Earnings (Accumulated Deficit) -429M USD -208%
Stockholders' Equity Attributable to Parent 4.36B USD -15.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 4.81B USD -13.9%
Liabilities and Equity 5.06B USD -18.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -204M USD -5.99%
Net Cash Provided by (Used in) Financing Activities -188M USD +71.6%
Net Cash Provided by (Used in) Investing Activities -1.09B USD -112409%
Common Stock, Shares Authorized 7B shares 0%
Common Stock, Shares, Issued 690M shares -5.95%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.48B USD -72.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.25B USD -36.7%
Deferred Tax Assets, Valuation Allowance 701M USD +25.5%
Deferred Tax Assets, Gross 725M USD +26.8%
Operating Lease, Liability 100M USD +75.3%
Payments to Acquire Property, Plant, and Equipment 4.04M USD +318%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -336M USD -107%
Lessee, Operating Lease, Liability, to be Paid 177M USD +134%
Operating Lease, Liability, Current 9M USD -5.43%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11.3M USD +17.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.3M USD -3.53%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 15.1M USD +71%
Deferred Tax Assets, Operating Loss Carryforwards 469M USD +30.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 15.6M USD +75.5%
Additional Paid in Capital 4.77B USD -0.07%
Depreciation, Depletion and Amortization 1.1M USD -77.5%
Interest Expense 39.3M USD +14.6%